FridayMar 26, 2021 11:38 am

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) to Take Center Stage in Keynote Presentation at ‘Mining Disrupt’ Crypto Conference

ISW Holdings (OTC: ISWH), a global brand management holdings company with commercial operations in telehealth and cryptocurrency mining, today announced that ISWH will be represented in a keynote speaker slot at the Mining Disrupt conference (MiningDisrupt.com) this summer. The event is slated to take place at the Miami Airport Convention Center in Miami, Florida, on July 20-21, 2021. Robert Collazo, CEO of Bit5ive LLC, the company’s partner in major operations in its Cryptocurrency Mining and Mining Equipment division, will be the primary presenter on behalf of ISW Holdings in its keynote presentation. “Our model is about driving shareholder value in…

Continue Reading

FridayMar 26, 2021 11:12 am

QualityStocksNewsBreaks – Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) Appoints New Board Member to Lead R&D

Christina Lake Cannabis (CSE:CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) has appointed Salvatore Milia to its Board of Directors, effective immediately. Milia, who has invaluable experience in building large-scale information technology systems, recently created the company’s research and development committee; in his new board role, he will continue overseeing that committee and the company’s strategic plan to incorporate smart monitoring technology into its vertically integrated cannabis cultivation workflows. Milia will also focus on strengthening CLC’s crop yields and consistency while maintaining compliance with all applicable regulations. Christina Lake Cannabis recently signed a memorandum of understanding (“MOU”) with TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT)…

Continue Reading

FridayMar 26, 2021 10:48 am

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) CEO to Demo AiR Show Livestream Human Hologram Technology

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a leading provider of virtual and augmented reality (“AR”) experience technologies and services, today announced that it will be livestreaming its CEO, Evan Gappelberg, into homes at 10:30 a.m. ET today. Participants will be able to beam Gappelberg into their homes LIVE as he demonstrates Nextech’s AiR Show livestream human hologram technology. To participate, interested parties should download the AiR Show app, available via the Apple App Store or Google Play Store, to their mobile smartphone. From there, users should open the AiR Show app at 10:30 a.m. ET and enter…

Continue Reading

FridayMar 26, 2021 10:41 am

Perpetual Industries Inc. (PRPI) Is ‘One to Watch’

Perpetual Industries Inc. is expanding expertise and knowledge of energy-efficient technologies through the development of low-cost, green energy solutions for various industries The company’s R&D portfolio includes its proprietary XYO Balancing Technology, WindSilo, the XYO Washing Machine and Green Energy Mining (“GEM”) Systems The proprietary XYO Balancing Technology is optimized to eliminate vibration in a full spectrum of rotating equipment, creating virtually unlimited market potential The company recently acquired Worldwide Auctioneers, a classic car auction company The company’s boasts a seasoned management team led by Founder Brent W. Bedford, who has held the positions of President, Chairman and CEO since…

Continue Reading

FridayMar 26, 2021 10:30 am

QualityStocksNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Enters Purchase Agreements for $9.7M Direct Offering

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, has announced a registered direct offering. The company noted that it has entered into securities purchase agreements with institutional investors. The agreements outline the purchase of 2,190,000 shares of common stock in a registered direct offering priced at-the-market under Nasdaq rules. The agreement also includes a concurrent private placement up to 2,190,000 shares of common stock issued to investors as short-term warrants. Together the common stock and warrants are offered at $4.445, with the warrants having an exercise price of $4.32 per…

Continue Reading

FridayMar 26, 2021 9:56 am

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases FY 2020 Financial, Corporate Report

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and quality of life for patients who have unmet medical needs, has reported its financial numbers for the year ending Dec. 31, 2020; the company also reported a corporate update. High on the list of noteworthy achievements for the year 2020 was the selection of five U.S. clinical sites for the enrollment of patients for the company’s upcoming phase 2B trial; exclusive licensing agreements with Elion Oncology Inc. and Yuhan Corporation; the appointment of new board and executive team members; and the closing of an underwritten…

Continue Reading

FridayMar 26, 2021 9:26 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, FY 2020 Financial, Operational Results

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), reported is financial and operational results for the fourth quarter and fiscal year ending Dec. 31, 2020. The company also held a conference call on March 25, 2021, to discuss the new report. High on the list of significant achievements for the company was a full-year revenue increase of 15%; revenue for 2020 was $13.1 million compared to $11.4 million in 2019. Gross profit and margin was up for both the fourth quarter and…

Continue Reading

ThursdayMar 25, 2021 3:22 pm

QualityStocksNewsBreaks – Knightscope Inc. Reaches +21K Investor Mark

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that that it now has more than 21,000 investors. The update reads, “It is indeed a great honor to announce that in a short amount of time we've added another 1,000+ investors backing our efforts to better secure the USA! We are also honored to share a quote from one of our investors we thought you would find interesting: ‘Knightscope’s Autonomous Data Machines are as much a force multiplier and critical resource as any of the cutting-edge SWAT equipment that I acquired and deployed…

Continue Reading

ThursdayMar 25, 2021 2:49 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces 2nd Major DSD Expansion

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) today announced its latest partnership with Nevada Beverage Company, a Nevada-based direct-store-delivery (“DSD”) distributor. Under the agreement, Nevada Beverage will carry WTER’s full line of smooth-tasting Alkaline88 and A88 Infused flavored waters. “We are pleased to welcome Nevada Beverage Company to our growing DSD network. Nevada Beverage is a leading beverage distributor in Nevada, serving over 2,900 accounts with a territory encompassing 74% of the state population. As a best-in-class DSD provider, the partnership allows our waters to inundate another important market in the Southwest,” said Ricky Wright, president and CEO of…

Continue Reading

ThursdayMar 25, 2021 2:19 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Continues to Advance Toward Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced that the Wroclaw, Poland-based Lower Silesian Medical Chamber Ethics Committee gave WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) (“WPD”), the company’s sublicensee in Europe and Asia for its lead drug candidate, Berubicin, a positive opinion for its WPD-201 Clinical Trial Protocol. The protocol will be used in the planned forthcoming Berubicin clinical trial in adults with glioblastoma multiforme (“GBM”). This new development set the wheels in motion for the eventual approval of WPD’s studies — a multicenter Berubicin Phase 2 adult GBM trial and a multicenter pediatric Phase 1 malignant glioma trial. “WPD plans to…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered